Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. HALO Peers
See (HALO) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HALO | $53.96 | +3.73% | 6.5B | 14.07 | $3.76 | N/A |
| VRTX | $455.58 | +2.33% | 116.1B | -117.75 | -$3.84 | N/A |
| REGN | $548.63 | +4.50% | 56.8B | 13.59 | $39.35 | +0.16% |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $325.30 | -0.24% | 42B | -152.64 | -$2.11 | N/A |
| ARGX | $547.03 | -0.76% | 33.1B | 33.10 | $16.39 | N/A |
| BNTX | $107.98 | +1.42% | 25.8B | -29.37 | -$3.66 | N/A |
| BGNE | $184.71 | +0.49% | 20.2B | -22.55 | -$8.19 | N/A |
| RPRX | $36.04 | +0.03% | 20.2B | 14.64 | $2.45 | +2.40% |
| DNA-WT | $0.27 | -2.76% | 18.7B | N/A | N/A | N/A |
Stock Comparison
HALO vs VRTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, VRTX has a market cap of 116.1B. Regarding current trading prices, HALO is priced at $53.96, while VRTX trades at $455.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas VRTX's P/E ratio is -117.75. In terms of profitability, HALO's ROE is +1.22%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, HALO is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs REGN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, REGN has a market cap of 56.8B. Regarding current trading prices, HALO is priced at $53.96, while REGN trades at $548.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas REGN's P/E ratio is 13.59. In terms of profitability, HALO's ROE is +1.22%, compared to REGN's ROE of +0.15%. Regarding short-term risk, HALO is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs SGEN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, HALO is priced at $53.96, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas SGEN's P/E ratio is -57.19. In terms of profitability, HALO's ROE is +1.22%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, HALO is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ALNY Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ALNY has a market cap of 42B. Regarding current trading prices, HALO is priced at $53.96, while ALNY trades at $325.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ALNY's P/E ratio is -152.64. In terms of profitability, HALO's ROE is +1.22%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, HALO is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs ARGX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ARGX has a market cap of 33.1B. Regarding current trading prices, HALO is priced at $53.96, while ARGX trades at $547.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ARGX's P/E ratio is 33.10. In terms of profitability, HALO's ROE is +1.22%, compared to ARGX's ROE of +0.23%. Regarding short-term risk, HALO is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs BNTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BNTX has a market cap of 25.8B. Regarding current trading prices, HALO is priced at $53.96, while BNTX trades at $107.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BNTX's P/E ratio is -29.37. In terms of profitability, HALO's ROE is +1.22%, compared to BNTX's ROE of -0.04%. Regarding short-term risk, HALO is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs BGNE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, HALO is priced at $53.96, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BGNE's P/E ratio is -22.55. In terms of profitability, HALO's ROE is +1.22%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, HALO is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs RPRX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RPRX has a market cap of 20.2B. Regarding current trading prices, HALO is priced at $53.96, while RPRX trades at $36.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RPRX's P/E ratio is 14.64. In terms of profitability, HALO's ROE is +1.22%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, HALO is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs DNA-WT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, HALO is priced at $53.96, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, HALO's ROE is +1.22%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, HALO is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs SMMT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, SMMT has a market cap of 15.7B. Regarding current trading prices, HALO is priced at $53.96, while SMMT trades at $22.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas SMMT's P/E ratio is -62.35. In terms of profitability, HALO's ROE is +1.22%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, HALO is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs INCY Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, INCY has a market cap of 13.3B. Regarding current trading prices, HALO is priced at $53.96, while INCY trades at $68.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas INCY's P/E ratio is 343.65. In terms of profitability, HALO's ROE is +1.22%, compared to INCY's ROE of +0.01%. Regarding short-term risk, HALO is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs UTHR Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, UTHR has a market cap of 13.1B. Regarding current trading prices, HALO is priced at $53.96, while UTHR trades at $294.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas UTHR's P/E ratio is 11.59. In terms of profitability, HALO's ROE is +1.22%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, HALO is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs GMAB Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, GMAB has a market cap of 12.8B. Regarding current trading prices, HALO is priced at $53.96, while GMAB trades at $20.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas GMAB's P/E ratio is 12.20. In terms of profitability, HALO's ROE is +1.22%, compared to GMAB's ROE of +0.26%. Regarding short-term risk, HALO is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs KRTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, HALO is priced at $53.96, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas KRTX's P/E ratio is -28.09. In terms of profitability, HALO's ROE is +1.22%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, HALO is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs EXEL Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, EXEL has a market cap of 11.9B. Regarding current trading prices, HALO is priced at $53.96, while EXEL trades at $44.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas EXEL's P/E ratio is 19.92. In terms of profitability, HALO's ROE is +1.22%, compared to EXEL's ROE of +0.29%. Regarding short-term risk, HALO is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs MRNA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MRNA has a market cap of 11.1B. Regarding current trading prices, HALO is priced at $53.96, while MRNA trades at $30.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MRNA's P/E ratio is -3.29. In terms of profitability, HALO's ROE is +1.22%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, HALO is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs BMRN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BMRN has a market cap of 10.8B. Regarding current trading prices, HALO is priced at $53.96, while BMRN trades at $57.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BMRN's P/E ratio is 20.81. In terms of profitability, HALO's ROE is +1.22%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, HALO is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ASND Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ASND has a market cap of 10.4B. Regarding current trading prices, HALO is priced at $53.96, while ASND trades at $172.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ASND's P/E ratio is -25.83. In terms of profitability, HALO's ROE is +1.22%, compared to ASND's ROE of +1.91%. Regarding short-term risk, HALO is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs RXDX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, HALO is priced at $53.96, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RXDX's P/E ratio is -56.47. In terms of profitability, HALO's ROE is +1.22%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, HALO is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs IMGN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, HALO is priced at $53.96, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas IMGN's P/E ratio is -111.55. In terms of profitability, HALO's ROE is +1.22%, compared to IMGN's ROE of -1.43%. Regarding short-term risk, HALO is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs BPMC Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BPMC has a market cap of 8.3B. Regarding current trading prices, HALO is priced at $53.96, while BPMC trades at $128.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BPMC's P/E ratio is -51.34. In terms of profitability, HALO's ROE is +1.22%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, HALO is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CERE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, HALO is priced at $53.96, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CERE's P/E ratio is -16.47. In terms of profitability, HALO's ROE is +1.22%, compared to CERE's ROE of -0.43%. Regarding short-term risk, HALO is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs TECH Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, TECH has a market cap of 8.2B. Regarding current trading prices, HALO is priced at $53.96, while TECH trades at $52.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas TECH's P/E ratio is 62.75. In terms of profitability, HALO's ROE is +1.22%, compared to TECH's ROE of +0.06%. Regarding short-term risk, HALO is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs BBIO Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BBIO has a market cap of 8.1B. Regarding current trading prices, HALO is priced at $53.96, while BBIO trades at $42.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BBIO's P/E ratio is -12.02. In terms of profitability, HALO's ROE is +1.22%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, HALO is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ROIVW Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ROIVW has a market cap of 7.8B. Regarding current trading prices, HALO is priced at $53.96, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, HALO's ROE is +1.22%, compared to ROIVW's ROE of -0.03%. Regarding short-term risk, HALO is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs VRNA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, VRNA has a market cap of 7.7B. Regarding current trading prices, HALO is priced at $53.96, while VRNA trades at $91.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas VRNA's P/E ratio is -45.24. In terms of profitability, HALO's ROE is +1.22%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, HALO is less volatile compared to VRNA. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs ROIV Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ROIV has a market cap of 7.4B. Regarding current trading prices, HALO is priced at $53.96, while ROIV trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ROIV's P/E ratio is -14.59. In terms of profitability, HALO's ROE is +1.22%, compared to ROIV's ROE of -0.03%. Regarding short-term risk, HALO is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CORT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CORT has a market cap of 7.3B. Regarding current trading prices, HALO is priced at $53.96, while CORT trades at $71.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CORT's P/E ratio is 60.27. In terms of profitability, HALO's ROE is +1.22%, compared to CORT's ROE of +0.20%. Regarding short-term risk, HALO is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs AMRN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, AMRN has a market cap of 6.9B. Regarding current trading prices, HALO is priced at $53.96, while AMRN trades at $16.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas AMRN's P/E ratio is -3.82. In terms of profitability, HALO's ROE is +1.22%, compared to AMRN's ROE of -0.17%. Regarding short-term risk, HALO is less volatile compared to AMRN. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs RVMD Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RVMD has a market cap of 6.9B. Regarding current trading prices, HALO is priced at $53.96, while RVMD trades at $37.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RVMD's P/E ratio is -9.20. In terms of profitability, HALO's ROE is +1.22%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, HALO is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MDGL Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MDGL has a market cap of 6.7B. Regarding current trading prices, HALO is priced at $53.96, while MDGL trades at $306.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MDGL's P/E ratio is -16.83. In terms of profitability, HALO's ROE is +1.22%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, HALO is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs JAZZ Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, JAZZ has a market cap of 6.6B. Regarding current trading prices, HALO is priced at $53.96, while JAZZ trades at $109.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas JAZZ's P/E ratio is 14.87. In terms of profitability, HALO's ROE is +1.22%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, HALO is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs RETA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, HALO is priced at $53.96, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RETA's P/E ratio is -66.29. In terms of profitability, HALO's ROE is +1.22%, compared to RETA's ROE of +0.47%. Regarding short-term risk, HALO is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs IONS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, IONS has a market cap of 6.4B. Regarding current trading prices, HALO is priced at $53.96, while IONS trades at $43.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas IONS's P/E ratio is -13.36. In terms of profitability, HALO's ROE is +1.22%, compared to IONS's ROE of -0.92%. Regarding short-term risk, HALO is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs TGTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, TGTX has a market cap of 5.6B. Regarding current trading prices, HALO is priced at $53.96, while TGTX trades at $36.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas TGTX's P/E ratio is 141.60. In terms of profitability, HALO's ROE is +1.22%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, HALO is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs ABCM Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, HALO is priced at $53.96, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, HALO's ROE is +1.22%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, HALO is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ISEE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, HALO is priced at $53.96, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ISEE's P/E ratio is -22.44. In terms of profitability, HALO's ROE is +1.22%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, HALO is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs TLX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, TLX has a market cap of 5.4B. Regarding current trading prices, HALO is priced at $53.96, while TLX trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas TLX's P/E ratio is 178.67. In terms of profitability, HALO's ROE is +1.22%, compared to TLX's ROE of +0.14%. Regarding short-term risk, HALO is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs NUVL Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, NUVL has a market cap of 5.2B. Regarding current trading prices, HALO is priced at $53.96, while NUVL trades at $80.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas NUVL's P/E ratio is -17.65. In terms of profitability, HALO's ROE is +1.22%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, HALO is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs AXSM Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, AXSM has a market cap of 5.1B. Regarding current trading prices, HALO is priced at $53.96, while AXSM trades at $104.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas AXSM's P/E ratio is -17.85. In terms of profitability, HALO's ROE is +1.22%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, HALO is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ALKS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ALKS has a market cap of 4.8B. Regarding current trading prices, HALO is priced at $53.96, while ALKS trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ALKS's P/E ratio is 13.80. In terms of profitability, HALO's ROE is +1.22%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, HALO is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ALPN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, HALO is priced at $53.96, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ALPN's P/E ratio is -101.52. In terms of profitability, HALO's ROE is +1.22%, compared to ALPN's ROE of -0.04%. Regarding short-term risk, HALO is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ADMA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ADMA has a market cap of 4.3B. Regarding current trading prices, HALO is priced at $53.96, while ADMA trades at $17.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ADMA's P/E ratio is 21.29. In terms of profitability, HALO's ROE is +1.22%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, HALO is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs PCVX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, PCVX has a market cap of 4.2B. Regarding current trading prices, HALO is priced at $53.96, while PCVX trades at $33.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas PCVX's P/E ratio is -8.26. In terms of profitability, HALO's ROE is +1.22%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, HALO is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs OPT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, HALO is priced at $53.96, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas OPT's P/E ratio is -1.52. In terms of profitability, HALO's ROE is +1.22%, compared to OPT's ROE of +2.60%. Regarding short-term risk, HALO is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CRSP Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CRSP has a market cap of 4.2B. Regarding current trading prices, HALO is priced at $53.96, while CRSP trades at $51.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CRSP's P/E ratio is -10.80. In terms of profitability, HALO's ROE is +1.22%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, HALO is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs SLNO Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, SLNO has a market cap of 4.2B. Regarding current trading prices, HALO is priced at $53.96, while SLNO trades at $85.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas SLNO's P/E ratio is -17.43. In terms of profitability, HALO's ROE is +1.22%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, HALO is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs RYTM Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RYTM has a market cap of 4.2B. Regarding current trading prices, HALO is priced at $53.96, while RYTM trades at $66.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RYTM's P/E ratio is -23.37. In terms of profitability, HALO's ROE is +1.22%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, HALO is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MRTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, HALO is priced at $53.96, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MRTX's P/E ratio is -4.82. In terms of profitability, HALO's ROE is +1.22%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, HALO is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs AKRO Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, AKRO has a market cap of 4.1B. Regarding current trading prices, HALO is priced at $53.96, while AKRO trades at $51.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas AKRO's P/E ratio is -13.71. In terms of profitability, HALO's ROE is +1.22%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, HALO is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs CYTK Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CYTK has a market cap of 4B. Regarding current trading prices, HALO is priced at $53.96, while CYTK trades at $34.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CYTK's P/E ratio is -6.36. In terms of profitability, HALO's ROE is +1.22%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, HALO is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs KRYS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, KRYS has a market cap of 4B. Regarding current trading prices, HALO is priced at $53.96, while KRYS trades at $142.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas KRYS's P/E ratio is 33.34. In terms of profitability, HALO's ROE is +1.22%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, HALO is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MRUS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MRUS has a market cap of 3.9B. Regarding current trading prices, HALO is priced at $53.96, while MRUS trades at $54.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MRUS's P/E ratio is -12.66. In terms of profitability, HALO's ROE is +1.22%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, HALO is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs ZLAB Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ZLAB has a market cap of 3.9B. Regarding current trading prices, HALO is priced at $53.96, while ZLAB trades at $35.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ZLAB's P/E ratio is -14.07. In terms of profitability, HALO's ROE is +1.22%, compared to ZLAB's ROE of -0.33%. Regarding short-term risk, HALO is more volatile compared to ZLAB. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs PTCT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, PTCT has a market cap of 3.9B. Regarding current trading prices, HALO is priced at $53.96, while PTCT trades at $49.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas PTCT's P/E ratio is 7.46. In terms of profitability, HALO's ROE is +1.22%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, HALO is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs RYZB Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, HALO is priced at $53.96, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RYZB's P/E ratio is -57.86. In terms of profitability, HALO's ROE is +1.22%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, HALO is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CBAY Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, HALO is priced at $53.96, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CBAY's P/E ratio is -32.81. In terms of profitability, HALO's ROE is +1.22%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, HALO is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ACAD Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ACAD has a market cap of 3.6B. Regarding current trading prices, HALO is priced at $53.96, while ACAD trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ACAD's P/E ratio is 15.59. In terms of profitability, HALO's ROE is +1.22%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, HALO is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs ACLX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ACLX has a market cap of 3.6B. Regarding current trading prices, HALO is priced at $53.96, while ACLX trades at $66.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ACLX's P/E ratio is -21.64. In terms of profitability, HALO's ROE is +1.22%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, HALO is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs SWTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, HALO is priced at $53.96, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas SWTX's P/E ratio is -13.78. In terms of profitability, HALO's ROE is +1.22%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, HALO is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs RNA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RNA has a market cap of 3.4B. Regarding current trading prices, HALO is priced at $53.96, while RNA trades at $29.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RNA's P/E ratio is -9.49. In terms of profitability, HALO's ROE is +1.22%, compared to RNA's ROE of -0.27%. Regarding short-term risk, HALO is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs RARE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RARE has a market cap of 3.4B. Regarding current trading prices, HALO is priced at $53.96, while RARE trades at $39.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RARE's P/E ratio is -6.22. In terms of profitability, HALO's ROE is +1.22%, compared to RARE's ROE of -1.86%. Regarding short-term risk, HALO is less volatile compared to RARE. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs AAPG Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, AAPG has a market cap of 3.4B. Regarding current trading prices, HALO is priced at $53.96, while AAPG trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas AAPG's P/E ratio is -51.99. In terms of profitability, HALO's ROE is +1.22%, compared to AAPG's ROE of -2.50%. Regarding short-term risk, HALO is more volatile compared to AAPG. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs LEGN Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, LEGN has a market cap of 3.3B. Regarding current trading prices, HALO is priced at $53.96, while LEGN trades at $36.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas LEGN's P/E ratio is -30.75. In terms of profitability, HALO's ROE is +1.22%, compared to LEGN's ROE of -0.20%. Regarding short-term risk, HALO is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs SRRK Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, SRRK has a market cap of 3.2B. Regarding current trading prices, HALO is priced at $53.96, while SRRK trades at $35.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas SRRK's P/E ratio is -13.24. In terms of profitability, HALO's ROE is +1.22%, compared to SRRK's ROE of -1.18%. Regarding short-term risk, HALO is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs PTGX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, PTGX has a market cap of 3.1B. Regarding current trading prices, HALO is priced at $53.96, while PTGX trades at $51.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas PTGX's P/E ratio is 64.37. In terms of profitability, HALO's ROE is +1.22%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, HALO is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs VKTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, VKTX has a market cap of 3B. Regarding current trading prices, HALO is priced at $53.96, while VKTX trades at $27.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas VKTX's P/E ratio is -22.99. In terms of profitability, HALO's ROE is +1.22%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, HALO is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MLTX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MLTX has a market cap of 3B. Regarding current trading prices, HALO is priced at $53.96, while MLTX trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MLTX's P/E ratio is -20.27. In terms of profitability, HALO's ROE is +1.22%, compared to MLTX's ROE of -0.31%. Regarding short-term risk, HALO is more volatile compared to MLTX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs KYMR Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, KYMR has a market cap of 2.9B. Regarding current trading prices, HALO is priced at $53.96, while KYMR trades at $44.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas KYMR's P/E ratio is -14.29. In terms of profitability, HALO's ROE is +1.22%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, HALO is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs MORF Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MORF has a market cap of 2.9B. Regarding current trading prices, HALO is priced at $53.96, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MORF's P/E ratio is -14.88. In terms of profitability, HALO's ROE is +1.22%, compared to MORF's ROE of -0.22%. Regarding short-term risk, HALO is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs MOR Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MOR has a market cap of 2.9B. Regarding current trading prices, HALO is priced at $53.96, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MOR's P/E ratio is -12.64. In terms of profitability, HALO's ROE is +1.22%, compared to MOR's ROE of +2.51%. Regarding short-term risk, HALO is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MTSR Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MTSR has a market cap of 2.8B. Regarding current trading prices, HALO is priced at $53.96, while MTSR trades at $28.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MTSR's P/E ratio is -10.58. In terms of profitability, HALO's ROE is +1.22%, compared to MTSR's ROE of -0.63%. Regarding short-term risk, HALO is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs IMVT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, IMVT has a market cap of 2.8B. Regarding current trading prices, HALO is priced at $53.96, while IMVT trades at $16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas IMVT's P/E ratio is -5.92. In terms of profitability, HALO's ROE is +1.22%, compared to IMVT's ROE of -0.81%. Regarding short-term risk, HALO is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs KDNY Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, KDNY has a market cap of 2.7B. Regarding current trading prices, HALO is priced at $53.96, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas KDNY's P/E ratio is -12.47. In terms of profitability, HALO's ROE is +1.22%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, HALO is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CRNX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CRNX has a market cap of 2.7B. Regarding current trading prices, HALO is priced at $53.96, while CRNX trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CRNX's P/E ratio is -7.48. In terms of profitability, HALO's ROE is +1.22%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, HALO is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs APGE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, APGE has a market cap of 2.6B. Regarding current trading prices, HALO is priced at $53.96, while APGE trades at $45.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas APGE's P/E ratio is -12.26. In terms of profitability, HALO's ROE is +1.22%, compared to APGE's ROE of -0.19%. Regarding short-term risk, HALO is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MYOV Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MYOV has a market cap of 2.6B. Regarding current trading prices, HALO is priced at $53.96, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MYOV's P/E ratio is -14.05. In terms of profitability, HALO's ROE is +1.22%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, HALO is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs CPRX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CPRX has a market cap of 2.6B. Regarding current trading prices, HALO is priced at $53.96, while CPRX trades at $21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CPRX's P/E ratio is 13.50. In terms of profitability, HALO's ROE is +1.22%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, HALO is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs XENE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, XENE has a market cap of 2.5B. Regarding current trading prices, HALO is priced at $53.96, while XENE trades at $32.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas XENE's P/E ratio is -9.97. In terms of profitability, HALO's ROE is +1.22%, compared to XENE's ROE of -0.32%. Regarding short-term risk, HALO is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs MIRM Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, MIRM has a market cap of 2.4B. Regarding current trading prices, HALO is priced at $53.96, while MIRM trades at $48.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas MIRM's P/E ratio is -30.06. In terms of profitability, HALO's ROE is +1.22%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, HALO is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs PRVB Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, PRVB has a market cap of 2.4B. Regarding current trading prices, HALO is priced at $53.96, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas PRVB's P/E ratio is -16.43. In terms of profitability, HALO's ROE is +1.22%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, HALO is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs LBPH Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, LBPH has a market cap of 2.3B. Regarding current trading prices, HALO is priced at $53.96, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas LBPH's P/E ratio is -26.66. In terms of profitability, HALO's ROE is +1.22%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, HALO is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs DICE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, DICE has a market cap of 2.3B. Regarding current trading prices, HALO is priced at $53.96, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas DICE's P/E ratio is -21.91. In terms of profitability, HALO's ROE is +1.22%, compared to DICE's ROE of +0.56%. Regarding short-term risk, HALO is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs IBRX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, IBRX has a market cap of 2.3B. Regarding current trading prices, HALO is priced at $53.96, while IBRX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas IBRX's P/E ratio is -4.51. In terms of profitability, HALO's ROE is +1.22%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, HALO is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs APLS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, APLS has a market cap of 2.2B. Regarding current trading prices, HALO is priced at $53.96, while APLS trades at $17.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas APLS's P/E ratio is -9.93. In terms of profitability, HALO's ROE is +1.22%, compared to APLS's ROE of -1.00%. Regarding short-term risk, HALO is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs ARWR Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, ARWR has a market cap of 2.2B. Regarding current trading prices, HALO is priced at $53.96, while ARWR trades at $16.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas ARWR's P/E ratio is -12.98. In terms of profitability, HALO's ROE is +1.22%, compared to ARWR's ROE of -0.47%. Regarding short-term risk, HALO is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs LGND Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, LGND has a market cap of 2.2B. Regarding current trading prices, HALO is priced at $53.96, while LGND trades at $114.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas LGND's P/E ratio is -15.44. In terms of profitability, HALO's ROE is +1.22%, compared to LGND's ROE of -0.16%. Regarding short-term risk, HALO is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs CALT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CALT has a market cap of 2.1B. Regarding current trading prices, HALO is priced at $53.96, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CALT's P/E ratio is -22.73. In terms of profitability, HALO's ROE is +1.22%, compared to CALT's ROE of -1.67%. Regarding short-term risk, HALO is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs VCYT Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, VCYT has a market cap of 2.1B. Regarding current trading prices, HALO is priced at $53.96, while VCYT trades at $27.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas VCYT's P/E ratio is 65.05. In terms of profitability, HALO's ROE is +1.22%, compared to VCYT's ROE of +0.03%. Regarding short-term risk, HALO is more volatile compared to VCYT. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs VCEL Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, VCEL has a market cap of 2.1B. Regarding current trading prices, HALO is priced at $53.96, while VCEL trades at $41.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas VCEL's P/E ratio is 832.00. In terms of profitability, HALO's ROE is +1.22%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, HALO is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs RXRX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, RXRX has a market cap of 2.1B. Regarding current trading prices, HALO is priced at $53.96, while RXRX trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas RXRX's P/E ratio is -2.85. In terms of profitability, HALO's ROE is +1.22%, compared to RXRX's ROE of -0.75%. Regarding short-term risk, HALO is less volatile compared to RXRX. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs NAMS Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, NAMS has a market cap of 2B. Regarding current trading prices, HALO is priced at $53.96, while NAMS trades at $18.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas NAMS's P/E ratio is -9.90. In terms of profitability, HALO's ROE is +1.22%, compared to NAMS's ROE of -0.33%. Regarding short-term risk, HALO is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs DNLI Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, DNLI has a market cap of 2B. Regarding current trading prices, HALO is priced at $53.96, while DNLI trades at $14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas DNLI's P/E ratio is -5.22. In terms of profitability, HALO's ROE is +1.22%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, HALO is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs CGON Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, CGON has a market cap of 2B. Regarding current trading prices, HALO is priced at $53.96, while CGON trades at $27.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas CGON's P/E ratio is -17.57. In terms of profitability, HALO's ROE is +1.22%, compared to CGON's ROE of -0.17%. Regarding short-term risk, HALO is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs AGIO Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, AGIO has a market cap of 2B. Regarding current trading prices, HALO is priced at $53.96, while AGIO trades at $35.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas AGIO's P/E ratio is 2.98. In terms of profitability, HALO's ROE is +1.22%, compared to AGIO's ROE of +0.50%. Regarding short-term risk, HALO is less volatile compared to AGIO. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs KNSA Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, KNSA has a market cap of 2B. Regarding current trading prices, HALO is priced at $53.96, while KNSA trades at $27.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas KNSA's P/E ratio is -113.50. In terms of profitability, HALO's ROE is +1.22%, compared to KNSA's ROE of -0.04%. Regarding short-term risk, HALO is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.
HALO vs BCRX Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BCRX has a market cap of 1.9B. Regarding current trading prices, HALO is priced at $53.96, while BCRX trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BCRX's P/E ratio is -34.62. In terms of profitability, HALO's ROE is +1.22%, compared to BCRX's ROE of +0.11%. Regarding short-term risk, HALO is more volatile compared to BCRX. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs BLU Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BLU has a market cap of 1.9B. Regarding current trading prices, HALO is priced at $53.96, while BLU trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BLU's P/E ratio is -20.20. In terms of profitability, HALO's ROE is +1.22%, compared to BLU's ROE of -0.22%. Regarding short-term risk, HALO is more volatile compared to BLU. This indicates potentially higher risk in terms of short-term price fluctuations for HALO.
HALO vs BLTE Comparison
HALO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HALO stands at 6.5B. In comparison, BLTE has a market cap of 1.9B. Regarding current trading prices, HALO is priced at $53.96, while BLTE trades at $57.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HALO currently has a P/E ratio of 14.07, whereas BLTE's P/E ratio is -42.03. In terms of profitability, HALO's ROE is +1.22%, compared to BLTE's ROE of -0.32%. Regarding short-term risk, HALO is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.